Dr Lalchandani Labs Limited (BOM:541299)
8.37
0.00 (0.00%)
At close: Jun 19, 2026
Dr Lalchandani Labs Revenue
In the fiscal year ending March 31, 2026, Dr Lalchandani Labs had annual revenue of 41.86M INR, down -6.02%. Dr Lalchandani Labs had revenue of 21.35M in the half year ending March 31, 2026, with 2.46% growth.
Revenue
41.86M
Revenue Growth
-6.02%
P/S Ratio
1.56
Revenue / Employee
n/a
Employees
n/a
Market Cap
65.12M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 41.86M | -2.68M | -6.02% |
| Mar 31, 2025 | 44.54M | -3.56M | -7.39% |
| Mar 31, 2024 | 48.10M | -2.31M | -4.58% |
| Mar 31, 2023 | 50.40M | -62.39M | -55.31% |
| Mar 31, 2022 | 112.79M | 14.99M | 15.32% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 2, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Thyrocare Technologies | 8.29B |
| One Global Service Provider | 4.98B |
| Chandan Healthcare | 2.81B |
| Star Imaging and Path Lab | 885.27M |
| Modern Diagnostic & Research Centre | 814.48M |
| Invicta Diagnostic | 330.42M |
| Aspira Pathlab & Diagnostics | 249.82M |
| Clinitech Laboratory | 96.79M |